Alexander CM - Search Results

1

Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk.

Brodovicz KG, Kou TD, Alexander CM, O'Neill EA, Engel SS, Girman CJ, Goldstein BJ. Brodovicz KG, et al. Among authors: alexander cm. Diabetes Obes Metab. 2012 Dec;14(12):1123-8. doi: 10.1111/j.1463-1326.2012.01667.x. Epub 2012 Aug 14. Diabetes Obes Metab. 2012. PMID: 22831166

2

Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes.

Girman CJ, Kou TD, Cai B, Alexander CM, O'Neill EA, Williams-Herman DE, Katz L. Girman CJ, et al. Among authors: alexander cm. Diabetes Obes Metab. 2010 Sep;12(9):766-71. doi: 10.1111/j.1463-1326.2010.01231.x. Diabetes Obes Metab. 2010. PMID: 20649628

3

Risk of acute renal failure in patients with Type 2 diabetes mellitus.

Girman CJ, Kou TD, Brodovicz K, Alexander CM, O'Neill EA, Engel S, Williams-Herman DE, Katz L. Girman CJ, et al. Among authors: alexander cm. Diabet Med. 2012 May;29(5):614-21. doi: 10.1111/j.1464-5491.2011.03498.x. Diabet Med. 2012. PMID: 22017349

4

Recent trends in the characteristics of patients prescribed sitagliptin and other oral antihyperglycaemic agents in a large U.S. claims database.

Brodovicz KG, Kou TD, Alexander CM, O'Neill EA, Senderak M, Engel SS, Girman CJ. Brodovicz KG, et al. Among authors: alexander cm. Int J Clin Pract. 2013 May;67(5):449-54. doi: 10.1111/ijcp.12090. Int J Clin Pract. 2013. PMID: 23574104

5

Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.

Cook MN, Girman CJ, Stein PP, Alexander CM, Holman RR. Cook MN, et al. Among authors: alexander cm. Diabetes Care. 2005 May;28(5):995-1000. doi: 10.2337/diacare.28.5.995. Diabetes Care. 2005. PMID: 15855556

6

Characteristics of patients prescribed sitagliptin and other oral antihyperglycaemic agents in a large US claims database.

Cai B, Katz L, Alexander CM, Williams-Herman D, Girman CJ. Cai B, et al. Among authors: alexander cm. Int J Clin Pract. 2010 Nov;64(12):1601-8. doi: 10.1111/j.1742-1241.2010.02516.x. Int J Clin Pract. 2010. PMID: 20946268

7

Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care.

Cook MN, Girman CJ, Stein PP, Alexander CM. Cook MN, et al. Among authors: alexander cm. Diabet Med. 2007 Apr;24(4):350-8. doi: 10.1111/j.1464-5491.2007.02078.x. Epub 2007 Feb 28. Diabet Med. 2007. PMID: 17335466

8

Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes.

Tunceli K, Zhao C, Davies MJ, Brodovicz KG, Alexander CM, Iglay K, Radican L. Tunceli K, et al. Among authors: alexander cm. Patient Prefer Adherence. 2015 Jan 28;9:191-7. doi: 10.2147/PPA.S71346. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 25670888 Free PMC article.

9

Treatment escalation and rise in HbA1c following successful initial metformin therapy.

Nichols GA, Alexander CM, Girman CJ, Kamal-Bahl SJ, Brown JB. Nichols GA, et al. Among authors: alexander cm. Diabetes Care. 2006 Mar;29(3):504-9. doi: 10.2337/diacare.29.03.06.dc05-1937. Diabetes Care. 2006. PMID: 16505496

10

Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain.

Marrett E, Stargardt T, Mavros P, Alexander CM. Marrett E, et al. Among authors: alexander cm. Diabetes Obes Metab. 2009 Dec;11(12):1138-44. doi: 10.1111/j.1463-1326.2009.01123.x. Epub 2009 Sep 16. Diabetes Obes Metab. 2009. PMID: 19758360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters